FDA Approves XARACOLL® (bupivacaine HCl) Implant, a Non-Opioid, Drug-Device Treatment Option for Acute Postsurgical Pain Relief

XARACOLL is a unique, non-injectable drug-device combination in the form of a fully bioresorbable collagen implant containing bupivacaine hydrochloride. XARACOLL is placed directly into the surgical site during surgery and, after placement, releases bupivacaine immediately and over time. Full story.